Author: Fedora Pharmaceuticals, Inc.

Posted Date:

April 9, 2026

Fedora Pharmaceuticals Showcasing Antibiotic Candidate at 2026 European Society of Clinical Microbiology and Infectious Diseases Congress

Fedora Pharmaceuticals, Inc.

April 9, 2026
Fedora Pharmaceuticals Highlights Efficacy of Novel Antibiotic, FPI-2119, against Antimicrobial-resistant Gram-negative Bacteria at the 2026 IMARI Conference

Fedora Pharmaceuticals, Inc.

January 29, 2026